Atlantic Health Partners
The MDAFP has a strong resource – Atlantic Health Partners – to help our members successfully address the financial and administrative challenges of providing immunizations to your patients.
Top 5 Reasons for Pre-booking Vaccines for the 2022-2023 Flu Season
Based on the findings from the annual Centers for Disease Control (CDC) influenza report, flu activity was unusually low throughout the 2020-2021 flu season in the United States. Much of that decline can be attributed to COVID-19 precautions including wearing face masks, increased hand washing, quarantining, and limiting travel. These are all effective methods for preventing the spread of illnesses, but with COVID-19 restrictions beginning to lift or relax across the country, it is difficult to predict the full impact this will have on the upcoming flu season. While flu season typically begins in October, it is never too early for physician practices and clinics to begin preparing. Below are five significant benefits of reserving your influenza vaccine supply for the 2022-2023 season.
1: Reliable Inventory
Vaccines are produced by private manufacturers who are taking measures such as extending manufacturing timelines to ensure they can meet the robust demand for vaccines and supplies. Though influenza manufacturers are not currently anticipating supply shortages, pre-booking provides a safeguard against any potential supply chain delays and helps maintain continuous inventory between shipments. The CDC recommends healthcare facilities pre-book their influenza vaccines between January and March.
2: Caregiver Wellbeing
In order to effectively care for others, caregivers must remain physically and mentally healthy. Healthcare organizations can promote a healthy workplace and support their employees by making vaccinations to preventable diseases, like the flu, readily available at no cost. Pre-booking allows providers to take proactive measures to ensure there is vaccine inventory for their staff, allowing for pre-scheduled vaccinations, reduced sick days, and consistent operational efficiency.
3: Provider Competition
To remain competitive in an increasingly consumer-driven landscape, provider practices and clinics must be able to deliver exceptional and convenient care experiences. Pre-ordering not only allows practices and clinics to receive their vaccine at a favorable, competitive time, but also gives clinicians the opportunity proactively notify their patients that they will be administering flu shots in the fall so that patients can book appointments at a time that is convenient for their schedule.
4: Opportunity for Co-Administration
As the COVID-19 pandemic continues, health experts have reported decreased rates in routine vaccinations by 32% for adults and 36% for adolescents in 2020-2021. This decline has negative implications on public health in the United States and puts the opportunity of herd immunity against flu strains from previous seasons at risk. By offering co-administered influenza and COVID-19 vaccinations and booster shots, patients can conveniently schedule appointments to receive multiple vaccines in one visit. CDC guidance has offered this solution as a safe and effective method for increasing routine vaccinations in patient populations and reducing overall burden on the healthcare industry.
5: Favorable Pricing
Though pre-booking your vaccine supply requires an early commitment, partnering with a vaccine buying group that works directly with manufacturers and leading distributors can help ensure more favorable pricing, flexible payment options, and purchasing terms for your reservation.
Influenza vaccine distribution generally begins in August and continues through the fall until all vaccines have been distributed. Providers are encouraged to stay ahead of the market by taking a proactive approach to protecting their caregivers and communities against the flu.
If your practice or clinic has any questions or needs assistance with pre-booking their flu order, please contact us.
Herd Immunity: Protecting Individuals and Communities at Large
October 19, 2021 – As more people become vaccinated against COVID-19, the term “herd immunity” has emerged as a popular buzzword. The earliest use of the term can be traced back to a study examining bacterial transmission between a “herd” of mice in 1923. It was discovered that herd immunity occurs when a significant portion of a population becomes immune to an infectious disease. The principle of herd immunity has been critical to eradicating certain diseases. For example, when the World Health Organization launched its campaign to eradicate smallpox in the 1960s, widespread vaccination was key to halting the spread of the disease.
By preventing the spread of disease within communities and protecting those who cannot be vaccinated, herd immunity disrupts chains of infection. Below we review what herd immunity is, how it is developed, and why it’s important. READ MORE
Back to School Vaccines for Educators
September 22, 2021 – It’s that time of year again – back to school season. With the highly anticipated return to in person learning, health experts fear the lag in childhood vaccination rates could result in outbreaks of vaccine-preventable diseases. Although the Centers for Disease Control and Prevention (CDC) does not set vaccination requirements for schools, state immunization requirements for school children prevent the spread of serious diseases like polio, measles, tetanus, and whooping cough.
While it’s important for students to stay up to date with routine immunizations, it is also critical that adults’ educators receive their routine vaccines. As trustworthy role models, educators have a responsibility to model good immunization health. READ MORE
Key Vaccine Innovations Throughout History
August 24, 2021 – One of the most important inventions in human history is vaccines. Eradicating smallpox, preventing public health crises, and lowering mortality rates, vaccines have revolutionized global health. With the latest mRNA vaccine technology ushering in a new era of vaccinology, there has been a renewed interest in vaccine development for researchers.
Since the smallpox vaccine was first introduced in 1796, researchers have been innovating and updating vaccines to strengthen immunity. In recognition of National Immunization Month, we reviewed some of the key vaccine innovations throughout history that protected people of all ages against serious diseases. READ MORE
Travel Vaccines: Planning Responsibly for Safe, Healthy Travel
July 20, 2021 – As more people become vaccinated against COVID-19, countries around the world are re-opening for travel and tourism. After more than a year of travel restrictions, experts expect that pent-up wanderlust since the start of the pandemic will result in an upsurge of summer travel in 2021.
According to The Centers for Disease Control and Prevention’s (CDC) latest guidance regarding domestic and international travel, patients traveling should be fully vaccinated against COVID-19 to mitigate the risk of contracting and spreading the virus. But it’s not just COVID-19 that patients need protection from. Depending on the planned destination, patients may also need additional travel vaccines. By providing pre-travel consultation and care, providers have a significant role to play in preparing patients for safe, healthy travel in the coming months. READ MORE
Infant Immunizations: The First Step to Lifelong Immunity
June 16, 2021 – As the worst of the COVID-19 pandemic appears to be behind us, we are just beginning to face the economic and humanitarian impact. The consequences of public health crises can be substantial — hence, the significance of immunizations in preventing vaccine preventable disease outbreaks.
According to the Centers for Disease Control and Prevention (CDC), childhood immunizations between 1994 and 2018 has resulted in a net savings of $406 billion in direct costs and $1.9 trillion in total economic impact. With the highly anticipated return to in-person learning and play, infant immunizations are critical to preventing future outbreaks of vaccine preventable diseases for one of society’s most vulnerable age groups. As we inch towards a new normal and social activities resume, providers should emphasize the importance of infant immunizations to families who may have postponed their babies’ immunization appointments during the pandemic. READ MORE
Playing Catch-Up with Adolescent Immunization Before the Return to In-Person School
May 25, 2021 – As we learn more about the COVID-19 vaccines, federal guidance on who should receive them, and when, is changing quickly. As of late May 2021, The Centers for Disease Control and Prevention (CDC) has extended COVID-19 vaccine eligibility to include adolescents as young as 12 years old. The agency’s newest clinical guidance also approves co-administration stating, “COVID-19 vaccines and other vaccines may now be administered without regard to timing.” The updated guidance forgoes the previous two-week wait period before and after COVID-19 vaccine administration that posed challenges for providers trying to keep their patients on schedule with recommended immunizations, especially adolescents with various multi-dose immunizations. READ MORE
Protecting the Most Vulnerable: Prevnar 13® & Pneumovax 23 Current Recommendations
February 23, 2021 – According to published research, there are two periods in our lives when our immune systems are particularly weak: as growing babies and aging seniors. For that reason, there are a few immunizations that the Centers for Disease Control and Prevention (CDC) recommends for both the youngest and oldest members of our society — among them, pneumococcal vaccination.
With children, uptake for pneumococcal vaccination is high, with the CDC reporting that 92% of children have received at least three doses. But among seniors 65 years of age or older, reports from CDC researchers show that vaccination rates are below the previous Healthy People 2020 target of 90% uptake. READ MORE
Preparing for the 2021-2022 Flu Season: Lessons Learned from COVID-19
January 19, 2021 – Although flu season generally runs from October through April, as noted by the Centers for Disease Control and Prevention (CDC), preparation is a year-round activity. The typical preparation providers and medical practices perform is routine and doesn’t vary much from year to year – except in 2020.
The COVID-19 pandemic added an unexpected complexity that upended typical flu season preparations but also provided lessons for dealing with unusual public health circumstances. While we cannot predict what 2021 will bring, by examining the current flu season, providers and practices can adopt a few principles to better prepare for and adapt to future flu seasons.
Prepare for the unexpected
Typically, providers begin preparing for the start of flu season at the top of the year between January and March, when pre-booking begins. Providers pre-book and reserve their vaccine supply based on population needs, taking into account age mix, allergies, and even anticipated growth in patient roster.
But in 2020, these factors were nearly impossible for providers to predict with patients under stay-at-home orders decreasing visits to outpatient and primary care centers. While in-person visits were dwindling, CDC Director Robert Redfield was already warning of a fall “twindemic” with the flu and COVID-19, leaving providers ready for pre-booking wading between overpreparing and under-preparing for the 2020-2021 flu season.
ATLANTIC HEALTH PARTNERS EXPANDS ITS PROGRAM TO OFFER ADDITIONAL VACCINE SAVINGS!
Atlantic Health Partners has always been a strong resource for our members’ immunization efforts by offering the most favorable vaccine prices, terms, and purchasing support. We are pleased to share with you that Atlantic has expanded its program with the addition of GlaxoSmithKline (GSK) vaccines. This include options for practices interested in the GSK portfolio or for those practices just interested in using Bexsero (Meningitis B vaccine).
Atlantic now offers our members the full array of vaccine options to best meet your individual practice needs including:
- Most favorable pricing for Sanofi, Merck, GSK, and Dynavax vaccines
- A comprehensive flu program that includes Sanofi, GSK, and Seqirus products
- Meningoccocal B vaccine options that include both Trumenba or Bexsero
- No minimum quantity requirements to always receive most favorable pricing and terms
- Excellent and timely customer service including reimbursement support and advocacy
For information about the program please contact Jeff or Cindy at 800-741-2044 or email@example.com
Disclaimer: The Maryland Academy of Family Physicians (MDAFP) has entered into a business relationship with Atlantic Health Partners to offer our members discounts and exclusive savings. This or other affinity program relationships presented by the MDAFP in no way implies a MDAFP endorsement of the program, supplier, or vendor.